Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
Clinical trial NCT01253642 · TERMINATED
Trial details
- NCT number
- NCT01253642
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-12
- Primary completion
- 2016-09-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.